Control analysis between mifepristone and medroxyprogesterone in the treatment of patients with perimenopausal dysfunctional uterine bleeding / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 1182-1183, 2013.
Artigo
em Chinês
| WPRIM
| ID: wpr-435663
ABSTRACT
Objective To compare the effect between mifepristone and medroxyprogesterone in the treatment of patients with perimenopausal dysfunctional uterine bleeding.Methods 90 patients with perimenopausal dysfunctional uterine bleeding were randomly divided into two groups after diagnostic curettage surgery,the control group (n =45 cases) and the observation group(n =45 cases).The patients in the control group were treated with medroxyprogesterone,while the patients in the treatment group were treated with mifepristone.The endometrial thickness,anemia and menstrual flow were analyzed after three months.Results The total efficient rates were 71.1% in the control group and 88.9% in the observation group.There was a significant difference between two groups (P < 0.01).The endometrial thickness,anemia and menstrual flow were improved after treatment in both groups,which were more significantly improved in the treatment group (P < 0.05).Conclusion The mifepristone is significantly better than medroxyprogesterone acetate tablets in the control perimenopausal dysfunctional uterine bleeding.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Primary Medicine and Pharmacy
Ano de publicação:
2013
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS